38 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• RiceBran Technologies RIBT shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1 financial results.
• Tian Ruixiang Holdings Ltd TIRX shares jumped 33.1% to $16.00 after the company reported its financial results for the fiscal year ended October 31, 2020.
• NetSol Technologies, Inc. NTWK gained 25.3% to $5.40 after the company announced it signed a five-year contract worth multi-million-dollar renewal with a Japanese automotive customer in APAC.
• Aldeyra Therapeutics, Inc. ALDX shares jumped 24.9% to $13.86 after the company announced positive top-line results from the Phase 3 INVIGORATE study of 0.25% reproxalap ophthalmic solution, an investigational new drug, in patients with allergic conjunctivitis. The clinical trial successfully achieved statistical significance for the primary endpoint and all secondary endpoints, it added.
• First Choice Bancorp FCBP gained 24% to $30.12 after the company reported a rise in Q1 earnings.
• The Aaron's Company, Inc. AAN surged 22% to $32.24 after the company reported better-than-expected Q1 results.
• Trueblue Inc TBI rose 22% to $28.10 after the company swung to a Q1 profit.
• Vaxart, Inc. VXRT gained 18.3% to $7.17.
• Mechanical Technology, Incorporated MKTY shares gained 16.7% to $9.04 after the company priced its 2,419,355 share common stock offering at $6.20 per unit, for proceeds of $15 million.
• DermTech, Inc. DMTK surged 15.9% to $47.72 after the company announced the launch DermTech PLAplusTM, its test for the enhanced early detection of melanoma.
• Heidrick & Struggles International, Inc. HSII jumped 15% to $43.37 after the company reported better-than-expected Q1 results and issued Q2 sales guidance above estimates.
• Crocs, Inc. CROX gained 15% to $97.66 after the company reported better-than-expected Q1 results. Crocs said it sees Q2 sales growth of 60%-70% and FY21 sales growth of 40%-50%.
• Corporación América Airports S.A. CAAP rose 13.5% to $5.90.
• Cerecor Inc. CERC surged 13.4% to $2.96.
• Arcadia Biosciences, Inc. RKDA gained 13.4% to $3.1794. Arcadia Biosciences recently received Health Canada approval for GoodHemp Varieties.
• Cullinan Oncology, Inc. CGEM shares rose 13% to $35.80. Morgan Stanley upgraded Cullinan Oncology from Equal-Weight to Overweight.
• Aravive, Inc. ARAV surged 12.2% to $6.05 as the company said first patient was dosed in Phase 3 registrational trial evaluating AVB-500 in patients with platinum resistant ovarian cancer.
• United Parcel Service, Inc. UPS gained 11.3% to $195.67 after the company reported better-than-expected Q1 results.
• Turning Point Brands, Inc. TPB jumped 9% to $52.93 after reporting strong quarterly sales.

Check out these big penny stock gainers and losers

Losers

• Protagenic Therapeutics, Inc. PTIX shares dipped 25% to $2.31 after the company priced an underwritten public offering of 3.18 million units at a public offering price of $4.15 per unit for aggregate gross proceeds of approximately $13.2 million. In connection with the offering, the company has received approval to list its common stock and warrants on the Nasdaq Capital Market.
• RealNetworks, Inc. RNWK fell 22.9% to $2.6301 after the company priced 8.25 million shares at $2.7 per share to raise $22.3 million in a secondary public offering.
• Sol-Gel Technologies Ltd. SLGL dropped 19.2% to $11.10 after the company issued an update on FDA review of EPSOLAY.
• Reviva Pharmaceuticals Holdings, Inc. RVPH dropped 17.2% to $7.20. Reviva Pharmaceuticals shares jumped 104% on Monday after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms.
• Cyclerion Therapeutics, Inc. CYCN shares declined 16.7% to $2.60. The company recently appointed Errol De Souza, Ph.D., to Board of Directors.
• MicroVision, Inc. MVIS fell 15.4% to $22.37 after surging 47% on Monday. The technology company has cemented its position as a “meme stock” and is spiking for the second straight session based on social media momentum.
• PQ Group Holdings Inc. PQG tumbled 14.1% to $14.34 after the company reported preliminary Q1 results and announced a secondary offering of 12,500,000 shares of common stock by selling shareholders.
• Hydrofarm Holdings Group, Inc. HYFM fell 12.8% to $54.00. The company announced it entered into an agreement to acquire HEAVY 16 for up to $78.1 million. The company also announced the launch of a proposed public offering of common stock.
• Medpace Holdings, Inc. MEDP fell 12.2% to $170.63 following Q1 results.
• Trxade Group, Inc. MEDS fell 11.5% to $4.31 after reporting a loss for its first quarter.
• Scienjoy Holding Corporation SJ dipped 11% to $9.70. The company recently announced it launched NFTs on its live-streaming platforms.
• Sphere 3D Corp. ANY fell 10.1% to $2.0778.
• Amkor Technology, Inc. AMKR shares declined 9.4% to $21.67 after the company reported Q1 results and issued Q2 guidance.
• Cadence Design Systems, Inc. CDNS shares fell 9.1% to $131.15 after the company reported Q1 earnings results.
• Mesoblast Limited MESO fell 9.1% to $7.38.
• TriNet Group, Inc. TNET fell 7.4% to $78.06 after the company posted Q1 results and issued Q2 forecast.
• InspireMD Inc NSPR shares dropped 7% to $6.83.
• Centene Corporation CNC shares dropped 6.6% to $61.66 following Q1 results.
• Tesla, Inc. TSLA fell 4.3% to $706.47. Tesla reported better-than-expected earnings and sales for its first quarter. Production was 180,338 vehicles in the first quarter, up 76% year-over-year, while deliveries climbed 109% year-over-year to 184,877.